General Information of Drug (ID: DMO4GBK)

Drug Name
vinburnine Drug Info
Synonyms eburnamonine
Cross-matching ID
PubChem CID
71203
ChEBI ID
CHEMBL4740
CAS Number
CAS 4880-88-0
TTD Drug ID
D0S4DT

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
IL-17 signaling pathway 1.93 1.26e-2 84/94 (89.36%) S100A9;S100A8;S100A7;...
Carbohydrate digestion and absorption 1.89 1.89e-2 37/47 (78.72%) MGAM;HK3;AKT3;...
Renin secretion 1.88 2.10e-2 61/69 (88.41%) CALML3;PRKACB;GUCY1A1;...
Rheumatoid arthritis 1.85 2.84e-2 78/93 (83.87%) CXCL8;MMP3;CXCL12;...
Circadian entrainment 1.84 2.52e-2 85/97 (87.63%) GRIA2;CALML3;PRKACB;...
Neutrophil extracellular trap formation 1.82 2.94e-2 101/189 (53.44%) FCGR3B;TLR4;C5AR1;...
Natural killer cell mediated cytotoxicity 1.80 2.70e-2 99/131 (75.57%) FCGR3B;GZMB;LCP2;...
T cell receptor signaling pathway 1.78 2.99e-2 93/104 (89.42%) LCP2;ITK;RASGRP1;...
TNF signaling pathway 1.76 4.48e-2 103/112 (91.96%) JAG1;MMP3;CXCL1;...
Chemokine signaling pathway 1.76 4.29e-2 163/192 (84.9%) CXCL8;CXCL12;CXCL1;...
Long-term potentiation 1.75 4.12e-2 61/67 (91.04%) GRIA2;CALML3;PRKACB;...
Viral protein interaction with cytokine and cytokine re... 1.74 3.99e-2 84/100 (84%) CXCL8;CXCL12;CXCL1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.006uM - 10uM 6H, 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.006uM - 6.66uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.006uM - 6.66uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.006uM - 6.66uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.006uM - 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.006uM - 10uM 6H, 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.006uM - 6.66uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.006uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.006uM - 6.66uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.006uM - 6.66uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.006uM - 6.66uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.006uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.006uM - 10uM 6H, 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.006uM - 6.66uM 24H